Bone Biologics Corporation
BBLG
$0.7497
$0.05988.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.77% | 52.93% | -27.75% | 6.64% | -32.03% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 144.68% | -46.14% | -25.43% | -25.97% | -27.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -33.08% | -40.69% | 97.78% | 0.00% | -- |
| Total Current Assets | -5.03% | 27.31% | -16.83% | 2.72% | -24.89% |
|
|
|||||
| Total Current Assets | -5.03% | 27.31% | -16.83% | 2.72% | -24.89% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -5.03% | 27.31% | -16.83% | 2.72% | -24.89% |
|
|
|||||
| Total Accounts Payable | 96.21% | -18.03% | 58.62% | -59.47% | -67.29% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -94.36% | 58.37% | 185.87% | -96.09% | 484.72% |
| Total Other Current Liabilities | -94.36% | 58.37% | 185.87% | -96.09% | 484.72% |
| Total Current Liabilities | 38.15% | -3.90% | 72.84% | -80.20% | -29.73% |
|
|
|||||
| Total Current Liabilities | 38.15% | -3.90% | 72.84% | -80.20% | -29.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.15% | -3.90% | 72.84% | -80.20% | -29.73% |
|
|
|||||
| Common Stock & APIC | 1.39% | 2.13% | 0.02% | 1.95% | 0.80% |
| Retained Earnings | -1.82% | -1.14% | -0.96% | -1.07% | -1.95% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -8.14% | 30.37% | -20.84% | 26.44% | -23.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.14% | 30.37% | -20.84% | 26.44% | -23.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.14% | 30.37% | -20.84% | 26.44% | -23.38% |
|
|
|||||